American journal of nephrology [Published on 30th June 2000] [Accessed on 19th July 2022] 4
Murdocca M, Capuano R, Pucci S, Cicconi R, Polidoro C, Catini A et al (2019) Targeting LOX-1 Inhibits Colorectal Cancer Metastasis in an Animal Model
Prostate Cancer A Phase 1/2 clinical trial evaluating gedatolisib for patients with metastatic castration resistant prostate cancer The CELC-G-201 Phase 1/2 clinical trial is evaluating gedatolisib plus darolutamide, an androgen receptor (AR) inhibitor, in patients previously treated with an AR inhibitor for metastatic castration resistant prostate cancer (mCRPC)
Increases the ability to maximally contract muscle fibres
doi: 10.1038/cr.2010.178 98 PasparakisM
Typical sites of psoriatic lesions include the scalp, elbows, knees, hands, feet, and the lumbosacral region (197, 200)